INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![gettyimages-1368252357 patient enrollment]( "Advancing Oncology Innovation With Adaptive Trial Designs")
Advancing Oncology Innovation With Adaptive Trial DesignsWhen a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
![GettyImages-545581230-lab-research-computer-tablet-teamwork]( "The Rise Of Targeted Modalities In Pharmaceutical Development")
The Rise Of Targeted Modalities In Pharmaceutical DevelopmentTargeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.
-
![altasciences manufacturing supply thumb]( "Successful Manufacturing Of Clinical Trial Supply")
Successful Manufacturing Of Clinical Trial SupplyFormulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.
-
![GettyImages-2148853397-whiteboard-people-strategy-thinking-writing-ipad]( "The Path Forward In Oncology Trials")
The Path Forward In Oncology TrialsA comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
Increasing Efficiency And Reducing Drug Waste10/2/2025
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic7/23/2024
How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.
-
Breaking Free From Process Paralysis In Clinical Trials1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
Insights From Facilitating Over A Billion Dollars In Vendor Contracts7/1/2025
By transforming vendor selection from a manual task into a data-driven, strategic process, sponsors can build stronger, more effective clinical trial teams.
-
Global Vaccine Trials Case Study5/22/2024
Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-1390380585 business, meeting, data, research, office]( "Empower Your Research Sites With A Full-Service Marketing Solution")
Built for Sites, Not Just Sponsors
Too many recruitment vendors focus solely on the sponsor’s bottom line, leaving sites stuck managing clunky spreadsheets, manual tracking, and outreach tasks without the infrastructure to scale.
-
![Quality Assurance iStock-1170250587.jpg]( "Quality Assurance")
Experienced quality assurance professionals establish quality structures and streamlined approaches to reduce risk and reinforce operational innovation in the changing landscape of clinical quality and compliance.
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Accelerating Biologics Through Development Milestones")
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.
-
![GettyImages-1012405368 biotech]( "Earn The Trust Of Biotechs And Emerging Pharma")
Backed by a global team of more than 3,000 professionals across 34 office locations, we deliver scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.
-
![GettyImages-1226390663-CRA- Clinical Research Associate]( "Starting A New Study? This One's For You")
Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.
